305 related articles for article (PubMed ID: 8876777)
1. Positron emission tomography metabolic data corrected for cortical atrophy using magnetic resonance imaging.
Labbé C; Froment JC; Kennedy A; Ashburner J; Cinotti L
Alzheimer Dis Assoc Disord; 1996; 10(3):141-70. PubMed ID: 8876777
[TBL] [Abstract][Full Text] [Related]
2. Brain FDG PET study of normal aging in Japanese: effect of atrophy correction.
Yanase D; Matsunari I; Yajima K; Chen W; Fujikawa A; Nishimura S; Matsuda H; Yamada M
Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):794-805. PubMed ID: 15759148
[TBL] [Abstract][Full Text] [Related]
3. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease.
Ibáñez V; Pietrini P; Alexander GE; Furey ML; Teichberg D; Rajapakse JC; Rapoport SI; Schapiro MB; Horwitz B
Neurology; 1998 Jun; 50(6):1585-93. PubMed ID: 9633698
[TBL] [Abstract][Full Text] [Related]
4. Correction of PET data for partial volume effects in human cerebral cortex by MR imaging.
Meltzer CC; Leal JP; Mayberg HS; Wagner HN; Frost JJ
J Comput Assist Tomogr; 1990; 14(4):561-70. PubMed ID: 2370355
[TBL] [Abstract][Full Text] [Related]
5. Partial volume effect-corrected FDG PET and grey matter volume loss in patients with mild Alzheimer's disease.
Samuraki M; Matsunari I; Chen WP; Yajima K; Yanase D; Fujikawa A; Takeda N; Nishimura S; Matsuda H; Yamada M
Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1658-69. PubMed ID: 17520250
[TBL] [Abstract][Full Text] [Related]
6. Anatomically guided voxel-based partial volume effect correction in brain PET: impact of MRI segmentation.
Gutierrez D; Montandon ML; Assal F; Allaoua M; Ratib O; Lövblad KO; Zaidi H
Comput Med Imaging Graph; 2012 Dec; 36(8):610-9. PubMed ID: 23046730
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of regional cerebral blood flow corrected for partial volume effect using O-15 water and PET: I. Theory, error analysis, and stereologic comparison.
Iida H; Law I; Pakkenberg B; Krarup-Hansen A; Eberl S; Holm S; Hansen AK; Gundersen HJ; Thomsen C; Svarer C; Ring P; Friberg L; Paulson OB
J Cereb Blood Flow Metab; 2000 Aug; 20(8):1237-51. PubMed ID: 10950386
[TBL] [Abstract][Full Text] [Related]
8. Selecting the most relevant brain regions to discriminate Alzheimer's disease patients from healthy controls using multiple kernel learning: A comparison across functional and structural imaging modalities and atlases.
Rondina JM; Ferreira LK; de Souza Duran FL; Kubo R; Ono CR; Leite CC; Smid J; Nitrini R; Buchpiguel CA; Busatto GF
Neuroimage Clin; 2018; 17():628-641. PubMed ID: 29234599
[TBL] [Abstract][Full Text] [Related]
9. The effect of brain atrophy on cerebral hypometabolism in the visual variant of Alzheimer disease.
Bokde AL; Pietrini P; Ibáñez V; Furey ML; Alexander GE; Graff-Radford NR; Rapoport SI; Schapiro MB; Horwitz B
Arch Neurol; 2001 Mar; 58(3):480-6. PubMed ID: 11255453
[TBL] [Abstract][Full Text] [Related]
10. In vivo hippocampal glucose metabolism in mesial temporal lobe epilepsy.
Knowlton RC; Laxer KD; Klein G; Sawrie S; Ende G; Hawkins RA; Aassar OS; Soohoo K; Wong S; Barbaro N
Neurology; 2001 Oct; 57(7):1184-90. PubMed ID: 11591833
[TBL] [Abstract][Full Text] [Related]
11. Partial-Volume Effect Correction Improves Quantitative Analysis of 18F-Florbetaben β-Amyloid PET Scans.
Rullmann M; Dukart J; Hoffmann KT; Luthardt J; Tiepolt S; Patt M; Gertz HJ; Schroeter ML; Seibyl J; Schulz-Schaeffer WJ; Sabri O; Barthel H
J Nucl Med; 2016 Feb; 57(2):198-203. PubMed ID: 26541776
[TBL] [Abstract][Full Text] [Related]
12. Glucose hypometabolism is highly localized, but lower cortical thickness and brain atrophy are widespread in cognitively normal older adults.
Nugent S; Castellano CA; Goffaux P; Whittingstall K; Lepage M; Paquet N; Bocti C; Fulop T; Cunnane SC
Am J Physiol Endocrinol Metab; 2014 Jun; 306(11):E1315-21. PubMed ID: 24735889
[TBL] [Abstract][Full Text] [Related]
13. Neocortical temporal FDG-PET hypometabolism correlates with temporal lobe atrophy in hippocampal sclerosis associated with microscopic cortical dysplasia.
Diehl B; LaPresto E; Najm I; Raja S; Rona S; Babb T; Ying Z; Bingaman W; Lüders HO; Ruggieri P
Epilepsia; 2003 Apr; 44(4):559-64. PubMed ID: 12681005
[TBL] [Abstract][Full Text] [Related]
14. Mapping cerebral atrophy and hypometabolism on
Siti Aishah AA; Normala I; Faruque Reza M; M Iqbal S
Med J Malaysia; 2023 Jan; 78(1):46-53. PubMed ID: 36715191
[TBL] [Abstract][Full Text] [Related]
15. Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects.
Müller-Gärtner HW; Links JM; Prince JL; Bryan RN; McVeigh E; Leal JP; Davatzikos C; Frost JJ
J Cereb Blood Flow Metab; 1992 Jul; 12(4):571-83. PubMed ID: 1618936
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators.
Alavi A; Newberg AB; Souder E; Berlin JA
J Nucl Med; 1993 Oct; 34(10):1681-7. PubMed ID: 8410281
[TBL] [Abstract][Full Text] [Related]
17. Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging.
Meltzer CC; Zubieta JK; Brandt J; Tune LE; Mayberg HS; Frost JJ
Neurology; 1996 Aug; 47(2):454-61. PubMed ID: 8757020
[TBL] [Abstract][Full Text] [Related]
18. Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction.
Quarantelli M; Berkouk K; Prinster A; Landeau B; Svarer C; Balkay L; Alfano B; Brunetti A; Baron JC; Salvatore M
J Nucl Med; 2004 Feb; 45(2):192-201. PubMed ID: 14960635
[TBL] [Abstract][Full Text] [Related]
19. Two novel PET image restoration methods guided by PET-MR kernels: Application to brain imaging.
Tahaei MS; Reader AJ; Collins DL
Med Phys; 2019 May; 46(5):2085-2102. PubMed ID: 30710342
[TBL] [Abstract][Full Text] [Related]
20. Correction for partial-volume effects on brain perfusion SPECT in healthy men.
Matsuda H; Ohnishi T; Asada T; Li ZJ; Kanetaka H; Imabayashi E; Tanaka F; Nakano S
J Nucl Med; 2003 Aug; 44(8):1243-52. PubMed ID: 12902414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
